Symptom | Patients experiencing symptom at disease presentation (our study) | Patients experiencing symptom throughout follow up care (our study) | Patients experiencing symptom at disease presentation or throughout care (Brunner et al. Review)[6] |
---|---|---|---|
(n = 21) | (n = 21) | (n = 160-230) (%) | |
Anorexia | 5 (23.8) | 1 (4.8) | NR |
Arthralgias | 3 (14.3) | 3 (14.3) | 33/230 (14.3) |
Back Pain | 3 (14.3) | 3 (14.3) | NR |
Blurred Vision | 2 (9.5) | 2 (9.5) | NR |
Carotidynia | 1 (4.8) | 1 (4.8) | NR |
Chest Pain | 1 (4.8) | 3 (14.3) | 15/199 (7.5) |
Dizziness | 0 (0.0) | 1 (4.8) | NR |
Dyspnea | 4 (19.1) | 4 (19.1) | 49/210 (23.3) |
Emesis | 2 (9.5) | 0 (0.0) | 40/199 (20.1) |
Fatigue | 8 (38.0) | 6 (28.6) | NR |
Fever | 3 (14.3) | 5 (23.8) | 47/160 (29.4) |
Headache | 3 (14.3) | 3 (14.3) | 66/210 (31.4) |
Jaw Pain | 2 (9.5) | 0 (0.0) | NR |
Lower Extremity Claudication | 3 (14.3) | 3 (14.3) | NR |
Myalgias | 0 (0.0) | 3 (14.3) | NR |
Night Sweats | 3 (14.3) | 1 (4.8) | NR |
Non- Post-Prandial Abdominal Pain | 1 (4.8) | 2 (9.5) | 33/199 (16.6) |
Palpitations | 1 (4.8) | 1 (4.8) | 29/199 (14.6) |
Paresthesias | 1 (4.8) | 4 (19.1) | NR |
Post-Prandial Abdominal Pain | 1 (4.8) | 2 (9.5) | NR |
Rash/Skin Lesions | 0 (0.0) | 2 (9.5) | 12/230 (5.2) |
Seizure-like Activity | 2 (9.5) | 0 (0.0) | NR |
Syncope | 1 (4.8) | 2 (9.5) | 4/199 (2.0) |
Upper Extremity Claudication | 0 (0.0) | 3 (14.3) | NR |
Weight Loss | 10 (47.6) | 4 (19.1) | NR |